Due Diligence for EPLN (OTC BB). Have entered and will wait on the next filings. About time for them.
Epolin, Inc.
358-364 Adams St.
Newark, NJ 07105
Phone: (973) 465-9495
Fax: (973) 465-5353
E-mail: info@epolin.com
Company Web Site: www.epolin.com/
Company Officers: (Full qualifications listed below.)
Murray S. Cohen, CEO & Board Chairman
James Ivchenko, President & Director
Chester C. Swasey, VP For Sales & Mktg
Directors:
James Ivchenko
Chester C. Swasey
Claire Bluestein
Morris Dunkel
Abdelhamid A.H. Ramadan
Epolin, Inc. is engaged in the commercial development, production
and sale of specialty chemicals, including certain dyes which have
the ability to absorb near infrared radiation. Applications for the
dyes include: Laser Protection, Welding, Sunglasses, Optical Filters,
Glazing, and Imaging.
Complete specifications and descriptions of the dyes:
www.epolin.com/products.html
Additional products include specialty chemicals that serve as
intermediates and additives used in the adhesive, plastic,
aerospace, pharmaceutical, flavors and fragrance industries.
Patents held by EPLN via IBM Patent Search:
www.patents.ibm.com/details?pn=US05686639__
www.patents.ibm.com/details?pn=US04891436__
www.patents.ibm.com/details?pn=US04738899__
Patents held by EPLN Principal Officers via IBM Patent Search:
www.patents.ibm.com/details?pn=US04243824__
www.patents.ibm.com/details?pn=US04207213__
www.patents.ibm.com/details?pn=US04205191__
www.patents.ibm.com/details?pn=US04154721__
www.patents.ibm.com/details?pn=US04152303__
www.patents.ibm.com/details?pn=US04094999__
Share Information:
( www.marketguide.com/mgi/snap/A1BB9.html )
Outstanding Shares: 11,560,000 (11.56M)
Public Float: 4,900,000 (4.9M)
52 Week High: $2.38
52 Week Low: $ .08
Employees: 8 Full-time employess per latest SEC filing.
Fully Reporting With SEC: (Files in January, April, July, October)
(
www.freeedgar.com/Search/FilingsResults.asp?SourcePage=CompanyList&CIK=797079&UseFrame=1&FormType=&DateFiled=&CompanyName=EPOLIN+INC+%2FNJ%2F
)
Sales For 3-Months Ending 5/31/99: $431,666
Earnings (Profit) For 3-Months Ending 5/31/99: $258,300
Annualized Sales Based on MRQ: $1,726,664
Annualized Earnings Based on MRQ: $1,033,200
Share Value Information: (As of 9/30/99)
Price/Earnings Ratio (TTM): 10.42
Price/Sales (TTM): 1.55
Price/Book (MRQ) 1.51
Price/Cash Flow (TTM): 8.62
Profit Margin (MRQ): 59.7%
Profit Margin (TTM): 22%
Per Share Data:
Earnings Per Share (TTM): $ 0.02
Sales Per Share (TTM): $ 0.16
Earnings Per Share (MRQ): $ 0.02
Sales Per Share (MRQ): $.037
Comparison to other stocks in their industry and sector:
www.marketguide.com/mgi/ratio/A1BB9.html
EPLN Internet Message Boards:
www.ragingbull.com/mboard/boards.cgi?board=EPLN
www.clearstation.com/cgi-bin/bbs/Individual_Stocks/EPLN/Discuss/?Cmd=list
EPLN Charts:
www.clearstation.com/cgi-bin/details?Event=peek&Symbol=epln
www.tscn.com/wsc/Corporate_Snapshot.html?PH=2&Symbol=EPLN&hdr2=4&hdr3=0&hdr1=EPLN
Miscellaneous Links:
Small article about Epolin in "Photonics Spectra" online magazine (1997):
www.laurin.com/Content/Oct97/Products/l_NEAR.html
Link to Epolin from "Chemical Insight Magazine" Online:
www.reedchemicals.com/edit/rcpdem/useast.html
Small article about EPLN dyes in "Optoelectronics World" magazine (1996):
www.optoelectronics-world.com/lfw/archive/1996/04/04prods.html
Member Directory of "The New Jersey Group of Small Chemical Businesses"
( James Ivchenko listed as a member.)
www.njchembus.org/njlist.html
Epolin Link in "American Ink Maker" magazine online:
www.inkmakeronline.com/web.htm
Epolin Link in NJ Pharmaceutical Company List at Rutgers:
www.libraries.rutgers.edu/rul/rr_gateway/research_guides/pharm/njbuz.shtml
Set forth below are brief accounts of the business experience during the
past five years of each director and executive officer of the Company and
each significant employee of the Company.
MURRAY S. COHEN has served as Director, Chief Executive Officer and
Chairman of the Board of the Company since June 1984. From June 1984 to
August 1994, Dr. Cohen was also President. Since May 1983, Dr. Cohen has
been an officer of Accort Labs, Inc., a wholly-owned subsidiary of the
Company. From January 1978 through May 1983, Dr. Cohen was the Director of
Research and Development for Apollo Technologies Inc., a company engaged in
the development of pollution control procedures and devices. Dr. Cohen was
employed as a Vice President and Technical Director of Borg-Warner
Chemicals from 1973 through January 1978, where his responsibilities
included the organization, project selection and project director of a 76
person technical staff which developed materials for a variety of plastic
products. He received a Bachelor of Science Degree from the University of
Missouri in 1949 and a Ph.D. in Organic Chemistry from the same institution
in 1953.
JAMES IVCHENKO has served as Director of the Company since September 1993,
President since August 1994, and from February 1992 to August 1994, he was
Technical Director and Vice President of Operations. Prior thereto, Mr.
Ivchenko was employed by Ungerer & Co. as Plant Manager for the Totowa, New
Jersey and Bethlehem, Pennsylvania facilities from May 1988 to May 1991.
Mr. Ivchenko has over 30 years of experience in the flavor, fragrance and
pharmaceutical intermediate industry. He received his Bachelor of Arts
Degree, Masters of Science and Masters of Business Administrations from
Fairleigh Dickinson University in New Jersey.
CHESTER C. SWASEY has served as Director of the Company since 1994 and Vice
President of Sales and Marketing since August 1994. From 1992 to 1994, Mr.
Swasey was employed as a Director of Marketing at Fairmount Chemical
Company. From 1989 to 1992, he was employed as Manager of New Business
Development at Union Carbide Corporation. Mr. Swasey has received several
United States patents and has published a variety of technical papers
related to the performance of plastics additives. Mr. Swasey received a
Bachelor of Science degree in Chemistry from the City College of New York
in 1965, and a Master of Business Administration degree from Fairleigh
Dickinson University in 1973.
CLAIRE BLUESTEIN has served as Director of the Company since June 1984.
Since 1976, Dr. Bluestein has been president and sole shareholder of Captan
Associates, Inc., a company engaged in the development of materials for
commercial applications of radiation curing technology. Dr. Bluestein has
been issued several patents by the United States Department of Commerce,
Trademark and Patent Offices and has published a variety of chemistry
related articles. Dr. Bluestein received her Bachelor of Arts Degree from
the University of Pennsylvania in 1947. In 1948 she received a Master of
Science Degree and in 1950 a Ph.D. in Organic Chemistry from the University
of Illinois.
MORRIS DUNKEL has served as Director of the Company since June 1984. From
1976 through 1983, Dr. Dunkel was employed by Tenneco Chemicals, Inc., a
firm engaged in chemical production activities, in the capacities of
manager and director of Tenneco's organic chemicals research and
development division. Dr. Dunkel has been issued several United States
patents and has published numerous articles relating to chemical processes.
He received a Bachelor of Science Degree in 1950 from Long Island
University. Dr. Dunkel received a Master of Science Degree from Brooklyn
College in 1954 and Ph.D. in Organic Chemistry from the University of
Arkansas in 1956.
ABDELHAMID A.H. RAMADAN has been a Director of the Company since July 1994,
and has served as Manager for Research, Process Development and Quality
Assurance of the Company since November 1993. From March 1992 through
October 1993, he served as production manager at Celgene Corp., and from
1989 through February 1992, he served as Senior Chemist and Chemical
Hygiene Officer of the Company. From 1982 through 1988, Mr. Ramadan served
as Production Department Head at Tenneco Chemicals. Mr. Ramadan received a
Bachelor of Science Degree in Chemistry in 1963 from Ain Shams University -
Cairo - Egypt. |
